NCT06271044View on ClinicalTrials.gov

a. Reducing Radioiodine Treatment in Papillary Thyroid Cancer. RAILESS

NAActive, not recruitingINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2027

Conditions
to Omit Radioiodine Treatment Safely in Patients With Low -Risk Papillary Thyroid Cancer With Seize of 11-20mm
Interventions
OTHER

With radioiodine treatment

Postoperative radioiodine not given

PROCEDURE

With postoperative radioiodine treatment

Postoperative radioiodine given

All Listed Sponsors
lead

Helsinki University Central Hospital

OTHER